This topic contains a solution. Click here to go to the answer

Author Question: The half-life of tritium is 12.3 y. What is its mean life (time constant)? What will be an ideal ... (Read 73 times)

Marty

  • Hero Member
  • *****
  • Posts: 553
The half-life of tritium is 12.3 y. What is its mean life (time constant)?
 
  What will be an ideal response?

Question 2

If an electron is determined to be at x = 2.000 cm  0.0010 cm, what is the minimum uncertainty in the x component of its velocity? (melectron = 9.11  10-31 kg, h = 6.626  10-34 J  s)
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

gcook

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

17.7 y

Answer to Question 2

5.8 m/s




Marty

  • Member
  • Posts: 553
Reply 2 on: Jul 29, 2018
:D TYSM


JaynaD87

  • Member
  • Posts: 368
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Once thought to have neurofibromatosis, Joseph Merrick (also known as "the elephant man") is now, in retrospect, thought by clinical experts to have had Proteus syndrome. This endocrine disease causes continued and abnormal growth of the bones, muscles, skin, and so on and can become completely debilitating with severe deformities occurring anywhere on the body.

Did you know?

Alzheimer's disease affects only about 10% of people older than 65 years of age. Most forms of decreased mental function and dementia are caused by disuse (letting the mind get lazy).

Did you know?

Nearly all drugs pass into human breast milk. How often a drug is taken influences the amount of drug that will pass into the milk. Medications taken 30 to 60 minutes before breastfeeding are likely to be at peak blood levels when the baby is nursing.

Did you know?

Thyroid conditions may make getting pregnant impossible.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library